| Quinolone &fluoroquinolone | Folate biosythesis inhibitor | Phenicol | Tetracyline | Aminoglycosides | Beta-Lactamase Inhibitor | |||||||||||||
N (%) | O.R | P.V | N (%) | O.R | P.V | N (%) | O.R | P.V | N (%) | O.R | P.V | N (%) | O.R | P.V | N (%) | O.R | P.V | ||
Gender | Male | 2 (20) | 0.37 | 0.28 | 9 (42.86) | 6 | 0.12 | 3 (25) | 0.52 | 0.43 | 4 (33.33) | - | - | 19 (34.48) | - | - | 8 (47.06) | - | - |
Female | 8 (80) | R | - | 12 (57.14) | R | - | 9 (75) | R | - | 8 (66.67) | - | - | 19 (65.52) | - | - | 9 (52.94) | - | - | |
Residence | MN | 9 (90) | - | - | 18 (85.71) | - | - | 12 (100) | - | - | 10 (83.33) | - | - | 26 (89.60) | - | - | 14 (82.35) | - | - |
MR | 0 | - | - | 1 (4.76) | - | - | 0 | - | - | 0 | - | - | 1 (3.45) | - | - | 1 (3.33) | - | - | |
VU | 1 (10) | - | - | 2 (9.58) | - | - | 0 | - | - | 2 (16.67) | - | - | 2 (6.90) | - | - | 2 (6.67) | - | - | |
Age category | 0 - 50 | 9 (90) | - | - | 14 (66.67) | - | - | 9 (75) | - | - | 7 (58.33) | - | - | 22 (75.86) | - | - | 13 (76.47) | - | - |
51 - 100 | 1 (10) | - | - | 2 (9.52) | - | - | 0 | - | - | 1 (8.33) | - | - | 2 (6.90) | - | - | 2 (11.76) | - | - | |
101 - 150 | 0 | - | - | 4 (19.05) | - | - | 2 (16.67) | - | - | 3 (2.91) | - | - | 4 (13.79) | - | - | 2 (11.76) | - | - | |
151 - 200 | 0 | - | - | 1 (4.76) | - | - | 1 (8.33) | - | - | 1 (8.33) | - | - | 1 (3.45) | - | - | 0 | - | - | |
Symptoms | D | 2 (20) | 0.04 | 0.002 | 19 (90.48) | - | - | 8 (66.67) | 1.27 | 0.75 | 11 (91.67) | 13.7 | 0.02 | 19 (65.52) | - | - | 14 (82.35) | 7.46 | 0.02 |
ND | 8 (80) | R | - | 2 (9.52) | - | - | 4 (33.33) | R | - | 1 (8.33) | R | - | 10 (34.48) | - | - | 3 (17.65) | R | - |